The effect of vitamin D supplement in subjects with type 2 diabetes mellitus

The effect of vitamin D supplement in glycemic control and lipid profile in type 2 diabetes mellitus (DM): an intervention study

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12614000594628

Enrollment

100

Registered

2014-06-04

Start date

2014-03-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Vitamin D supplement may help in glycemic control and lipid profile in subjects with diabetes mellitus (DM). Our subjects will take 4500 IU/ day of vitamin D tables for two months. Physical examination and some laboratory measures will be formed before and after vitamin D supplement. The laboratory measures are fasting blood glucose, glycated hemoglobin, lipid profile. We will compare these measures to explore the effect of vitamin D in those with diabetes mellitus.

Interventions

Each diabetic subject will take 4500 IU/day of vitamin D3 oral drops for two months. During this period, patients will advise to record any compliance or possible side effects of the drug. After 2 months, all physical examination and laboratory measures that had done at first visit will be repeated.

Study design

Allocation

Non-randomised trial

Intervention model

Single group

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

40 Years to 60 Years

Healthy volunteers

Inclusion criteria

Adult subjects with type 2 diabetes mellitus

Exclusion criteria

We should exclude any subjects with hepatic, renal malignancy, bone disease, gall bladder disease, and gastrointestinal disease, history of anticonvulsants, calcium, or vitamin D intake for the last 3 months

Outcome results